Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
DEKA Biosciences
DEKA Biosciences
EBG MedAustron GmbH
Cyteir Therapeutics, Inc.
ImmunityBio, Inc.
Eli Lilly and Company
Tyme, Inc
ImmunityBio, Inc.
CSPC Ouyi Pharmaceutical Co., Ltd.
ImmunityBio, Inc.
ImmunityBio, Inc.
Genzada Pharmaceuticals USA, Inc.
Lumos Pharma
Eli Lilly and Company
Incyte Corporation
Celgene
Incyte Corporation
PharmaMar
Samsung Pharmaceutical Co., Ltd.
Hoffmann-La Roche
Sanofi
Hoffmann-La Roche
AstraZeneca